Nuwellis (NUWE) Operating Leases (2019 - 2025)

Nuwellis (NUWE) reported Operating Leases of $67000.0 for Q4 2025, down 78.18% on a YoY basis from $307000.0 in Q4 2024, and down 47.66% quarter-over-quarter from $128000.0 in Q3 2025.

Nuwellis (NUWE) Operating Leases (2019 - 2025) Analysis & Trends

Nuwellis has reported Operating Leases for 7 years, with the latest figure at $67000.0 in Q4 2025.

  • For the quarter ending Q4 2025, Operating Leases fell 78.18% year-over-year to $67000.0; the trailing twelve-month figure through Dec 2025 stood at $67000.0 (down 78.18% YoY), and the FY2025 full-year result was $67000.0, down 78.18% from the prior year.
  • Operating Leases for Q4 2025 stood at $67000.0, down from $128000.0 in the prior quarter.
  • The five-year high for Operating Leases was $956000.0 in Q4 2021, with the low at $67000.0 in Q4 2025.
  • Historically, Operating Leases has averaged $530941.2 across 5 years, with a median of $544000.0 in 2023.
  • Annual changes were most pronounced in 2021 — Operating Leases surged 1638.18% — and 2025, when it plunged 78.18%.
  • Nuwellis' Operating Leases stood at $956000.0 in 2021, then fell by 20.5% to $760000.0 in 2022, then fell by 28.42% to $544000.0 in 2023, then plunged by 43.57% to $307000.0 in 2024, then sank by 78.18% to $67000.0 in 2025.
  • The last three Operating Leases figures came in at $67000.0 (Q4 2025), $128000.0 (Q3 2025), and $189000.0 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn
10 Nuwellis 279,710.00 -1.80 Mn 1.68 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 67,000.00
Sep 30, 2025 128,000.00
Jun 30, 2025 189,000.00
Mar 31, 2025 249,000.00
Dec 31, 2024 307,000.00
Sep 30, 2024 368,000.00
Jun 30, 2024 428,000.00
Mar 31, 2024 488,000.00
Dec 31, 2023 544,000.00
Sep 30, 2023 601,000.00
Jun 30, 2023 654,000.00
Mar 31, 2023 708,000.00
Dec 31, 2022 760,000.00
Sep 30, 2022 810,000.00
Jun 30, 2022 860,000.00
Mar 31, 2022 909,000.00
Dec 31, 2021 956,000.00
Dec 31, 2020 55,000.00
Sep 30, 2020 108,000.00
Jun 30, 2020 160,000.00